Accelerating ADC Innovation …because patients are waiting February 1, 2023 Legal Disclaimer Thispresentationcontains“forward-looking”statementsandinformationwithinthemeaningofthePrivateSecuritiesLitigationReformActof1995.Thesestatements maybeidentifiedbywordssuchas“aims,”“anticipates,”“believes,”“could,”“estimates,”“expects,”“forecasts,”“goal,”“intends,”“may,”“plans,”“possible,”“potential,” “seeks,” “will” and variations of these words or similar expressions, although not all forward-looking statements cont ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Jason Fredette - SVP, IR and Corporate Communications Anna Protopapas - President and CEO Arvin Yang - Chief Medical Officer Brian DeSchuytner - CFO Conference Call Participants Jonathan Chang - SVB Securities Ashiq Mubarack - Citi Asthika Goonewardene - Truist Securities Boris Peaker - Cowen Operator Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2022 Co ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38129 Mersana Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 04-3562403 (State ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations and Corporate Communications Anna Protopapas - President and Chief Executive Officer Arvin Yang - Senior Vice President and Chief Medical Officer Brian DeSchuytner - Senior Vice President and Chief Financial Office Conference Call Participants Jonathan Chang - SVB Securities Colleen Kusy - Baird Kaveri Pohlman - BTIG David Niere ...

Accelerating ADC Innovation …because patients are waiting September 2022 Legal Disclaimer This presentation contains "forward-looking" statements and information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will" and variations of these words or similar expressions, although no ...

Accelerating ADC Innovation …because patients are waiting August 2022 Legal Disclaimer This presentation contains "forward-looking" statements and information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will" and variations of these words or similar expressions, although not a ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations and Corporate Communications Anna Protopapas - President, CEO & Director Arvin Yang - Senior VP & Chief Medical Officer Brian DeSchuytner - Senior VP & CFO Conference Call Participants Jonathan Chang - SVB Securities Colleen Kusy - Baird Operator Good afternoon, and welcome to Mersana Therapeutics Second Quarter 2022 Conference Ca ...

Accelerating ADC Innovation …because patients are waiting August 2022 Legal Disclaimer This presentation contains "forward-looking" statements and information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will" and variations of these words or similar expressions, although not a ...

Accelerating ADC Innovation …because patients are waiting June 2022 Legal Disclaimer This presentation contains "forward-looking" statements and information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will" and variations of these words or similar expressions, although not all ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations and Corporate Communications Anna Protopapas - President, CEO & Director Arvin Yang - Senior VP & Chief Medical Officer Tim Lowinger - Chief Science & Technology Officer Brian DeSchuytner - Senior VP & CFO Conference Call Participants Jonathan Chang - SVB Leerink Boris Peaker - Cowen Daniel Wolle - JPMorgan Colleen Kusy - Baird David ...